KRChoksey has come out with its first quarter (April-June’ 21) earnings estimates for the Pharma sector. The brokerage house expects Cadila Healthcare to report net profit at Rs 744 crore up 63.9% year-on-year (up 28.7% quarter-on-quarter).
Net Sales are expected to increase by 8.7 percent Y-o-Y (up 5.4 percent Q-o-Q) to Rs 3,956 crore, according to KRChoksey.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 31 percent Y-o-Y (up 35 percent Q-o-Q) to Rs 1,068.1 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Read More